Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
Background: Intrahepatic cholestasis of pregnancy (ICP) seriously threatens the health of pregnant women and newborns. A various number of Chinese prescriptions and patent medicines combined with ursodeoxycholic acid (UDCA) are used for treating ICP in China. However, there are still many doubts in...
Guardado en:
Autores principales: | Yinxiao Jiang, Haotian Li, Dan Song, Penghui Ye, Nuo Xu, Yuan Chen, Wenwen Zhang, Qichao Hu, Xiao Ma, Jianxia Wen, Yeyu Li, Yanling Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/521c47edec8646d5ba00be90bfaafb58 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EVALUATION OF RISK FACTORS FOR INTRAHEPATIC CHOLESTASIS OF PREGNANCY IN PATIENTS PRESENTING TO A TERTIARY CARE CENTRE
por: Rabiah Anwar, et al.
Publicado: (2021) -
Hepatotoxicidad por amoxicilina/ácido clavulánico: caso clínico
por: Soza R,Alejandro, et al.
Publicado: (1999) -
Evaluation of FGF-19 and β-klotho as biomarkers in patients with intrahepatic cholestasis of pregnancy
por: Ahter Tanay Tayyar, et al.
Publicado: (2018) -
Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment
por: Gunaydin M, et al.
Publicado: (2018) -
Liver disease in cystic fibrosis
por: Tombazzi,Claudio R, et al.
Publicado: (2001)